# Trading Cycle Report - 2026-05-26

**Environment**: staging
**Cycle triggered**: manual via `POST /api/trigger-cycle` at 08:10:24 UTC
**Total cycle duration**: ~2m 0s (08:10:24 → 08:12:25)
**Overall result**: 4/4 completed, 2 trades executed, 0 failed
**Deployment context**: First post-Track-1 (security-cluster-hardening) cycle on staging. Backend image `ghcr.io/vasilkosturski/agentic-trading-backend:latest`, pod `backend-55dccdc466-kc45g`. Public-by-default contract preserved (R9 rollback); `/api/runs/admin` ADMIN-gated; `/actuator/**` restricted to health,info publicly + ADMIN for env/metrics; CORS/WebSocket origins from `SecurityProperties.getAllowedOrigins()`; fail-fast on missing `JWT_SECRET`/`ADMIN_PASSWORD`.

---

## Cycle Summary (08:10 UTC)

| Agent  | Style              | Decision | Symbol | Qty | Price     | Total Cost  | Candidates                  |
|--------|--------------------|----------|--------|-----|-----------|-------------|-----------------------------|
| Ray    | Risk Parity        | HOLD     | —      | —   | —         | —           | KO, MCD, CL                 |
| Cathie | Growth Innovation  | SELL     | SNOW   | 45  | $172.20   | $7749.00    | MBLY, LI, BEAM, COIN        |
| Warren | Value Investor     | HOLD     | —      | —   | —         | —           | ORCL, TXN, CSCO, ABBV       |
| George | Contrarian Macro   | BUY      | COP    | 59  | $120.46   | $7107.14    | FCX, COP, MU, CAT           |

---

## Portfolio Snapshots (Latest)

| Agent  | Cash         | Holdings Value | Total Value   | Total P&L     | Return %   |
|--------|--------------|----------------|---------------|---------------|------------|
| Warren | $ 32,131.31 | $    78,870.44   | $ 111,001.75   | +$ 11,001.75   | + 11.00%    |
| George | $ 28,538.76 | $    75,399.99   | $ 103,938.75   | +$ 3,938.75   | +  3.94%    |
| Ray    | $ 35,937.15 | $    63,064.84   | $  99,001.99   | −$   998.01   | −  1.00%    |
| Cathie | $ 30,467.53 | $    92,296.41   | $ 122,763.94   | +$ 22,763.94   | + 22.76%    |

### Current Holdings

| Agent  | Symbol | Qty | Avg Price    | Cost Basis    |
|--------|--------|-----|--------------|---------------|
| Warren | AAPL   |  37 | $    283.58 | $  10,492.41 |
| Warren | BRK.B  |  36 | $    479.95 | $  17,278.22 |
| Warren | JNJ    |  26 | $    230.69 | $   5,997.94 |
| Warren | KO     |  69 | $     81.48 | $   5,622.12 |
| Warren | MCD    |  19 | $    301.84 | $   5,734.96 |
| Warren | MRK    |  63 | $    111.92 | $   7,050.96 |
| Warren | MSFT   |  18 | $    420.77 | $   7,573.86 |
| Warren | PG     |  23 | $    146.93 | $   3,379.39 |
| Warren | UNP    |  29 | $    269.48 | $   7,814.92 |
| Warren | V      |  20 | $    322.52 | $   6,450.40 |
| George | BHP    |  86 | $     84.60 | $   7,275.60 |
| George | CCJ    |  69 | $    104.75 | $   7,227.75 |
| George | COP    |  59 | $    120.46 | $   7,107.14 |
| George | FNV    |  30 | $    225.38 | $   6,761.40 |
| George | GOLD   | 169 | $     40.59 | $   6,859.71 |
| George | MP     |  77 | $     67.43 | $   5,192.11 |
| George | RTX    |  34 | $    180.91 | $   6,150.94 |
| George | SLB    | 120 | $     57.28 | $   6,873.60 |
| George | UEC    | 1152 | $     14.57 | $  16,782.19 |
| George | ZIM    | 270 | $     25.23 | $   6,812.10 |
| Ray    | AAPL   |  20 | $    308.82 | $   6,176.40 |
| Ray    | ATO    |  40 | $    187.26 | $   7,490.40 |
| Ray    | CVX    |  36 | $    191.10 | $   6,879.60 |
| Ray    | ITW    |  26 | $    248.12 | $   6,451.12 |
| Ray    | JNJ    |  27 | $    234.34 | $   6,327.18 |
| Ray    | MDT    |  72 | $     83.32 | $   5,999.04 |
| Ray    | PG     |  45 | $    142.01 | $   6,390.45 |
| Ray    | T      | 248 | $     24.74 | $   6,135.52 |
| Ray    | TRV    |  20 | $    301.53 | $   6,030.60 |
| Ray    | WM     |  25 | $    228.77 | $   5,719.25 |
| Cathie | AMD    |  16 | $    424.10 | $   6,785.60 |
| Cathie | ARM    |  31 | $    213.27 | $   6,611.37 |
| Cathie | ASML   |   4 | $   1478.41 | $   5,913.64 |
| Cathie | GOOGL  |  33 | $    318.28 | $  10,503.24 |
| Cathie | MSFT   |  11 | $    424.62 | $   4,670.82 |
| Cathie | NVDA   | 135 | $    183.91 | $  24,827.85 |
| Cathie | PATH   | 692 | $     10.93 | $   7,563.56 |
| Cathie | PLTR   |  56 | $    133.99 | $   7,503.44 |
| Cathie | TSLA   |  17 | $    426.01 | $   7,242.17 |

---

## Detailed Run Data

### Run 477: Ray (Risk Parity)

**Started**: 08:10:24 UTC | **Completed**: 08:12:22 UTC
**Status**: COMPLETED

#### Research Phase (75676ms)
**Candidates**: KO, MCD, CL

**Tool Calls** (6):
1. `brave_web_search(count=10, query="KO MCD CL dividend yield beta 2026 dividend aristocrat defensive low beta Coca-)`
2. `brave_web_search(count=10, query="McDonald's MCD dividend yield beta 2026 Morningstar Yahoo Finance McDonald's be)`
3. `brave_web_search(count=10, query="Colgate CL dividend yield beta 2026 Colgate-Palmolive beta dividend yield 2026 )`
4. `lookup_price_tool(symbol="KO")`
5. `lookup_price_tool(symbol="MCD")`
6. `lookup_price_tool(symbol="CL")`

**Research Notes**:
> I selected three low-beta, dividend‑focused, defensive names that fit a risk‑parity, all‑weather sleeve: KO (Coca‑Cola), MCD (McDonald’s), and CL (Colgate‑Palmolive). Each is a long-standing dividend grower with stable cash flows, low market beta, and exposure to consumer staples/defensive consumer services that tend to hold up in recessions and offer inflation pass‑through or pricing power. These names increase downside protection and income while providing sector diversification vs. the current book of industrials, energy, healthcare, and tech.
> 
> KO offers beverage exposure and very low beta with a long dividend history; MCD is a recession‑resilient franchised restaurant model with strong cash conversion and pricing power (helps in inflationary regimes); CL is a low‑volatility consumer staples play with a multi‑decade dividend streak and stable margins. Together they provide defensive ballast across recession/deflation and inflationary regimes while keeping overall portfolio volatility lower.

**Web Sources** (8):
- [Coca Cola KO Dividend History & Yield | Morningstar](https://www.morningstar.com/stocks/xnys/ko/dividends)
- [CocaCola - 54 Year Dividend History | KO | MacroTrends](https://www.macrotrends.net/stocks/charts/KO/cocacola/dividend-yield-history)
- [McDonald's Corporation (MCD) Stock Price, News, Quote & History - Yahoo Finance](https://finance.yahoo.com/quote/MCD/)
- [MCD - McDonald's Corp Dividends | Morningstar](https://www.morningstar.com/stocks/xnys/mcd/dividends)
- [Colgate-Palmolive Company (CL) Stock Price, News, Quote & History - Yahoo Finance](https://finance.yahoo.com/quote/CL/)
- [CL - Colgate-Palmolive Co Dividends | Morningstar](https://www.morningstar.com/stocks/xnys/cl/dividends)
- [None](None)
- [None](None)

#### Decision Phase (31019ms)
**Decision**: HOLD — x—

**Reasoning**:
- **rationale**:
  > Hold — all three candidates are high‑quality but would materially increase consumer‑staples exposure while the portfolio is at the 10/10 position limit and position‑size caps; better to wait or sell a holding first to create a deliberate replacement trade.
- **researchContext**:
  > Market Analyst candidates — KO (price $81.48; trailing P/E mid‑20s, dividend ~2.7–3.0%; sources: Morningstar, MacroTrends), MCD (price $282.27; P/E ~25–27, yield ~2.1–2.4%; source: Yahoo Finance, Morningstar), CL (price $90.61; trailing P/E ≈26, yield ~2.4–2.6%; source: Yahoo Finance, Morningstar). While each adds defensive income and low beta, none provides sufficient marginal diversification versus existing PG and other sleeves given the 10‑position limit and $5,390.57 per‑position cap; therefore HOLD and prefer a sale + replacement in a future cycle if a true uncorrelated diversifier emerges (sources cited above).
- **portfolioContext**:
  > Cash $35,937.15; positions 10/10 (WM 25 @$228.77, ITW 26 @$248.12, CVX 36 @$191.10, ATO 40 @$187.26, TRV 20 @$301.53, T 248 @$24.74, PG 45 @$142.01, MDT 72 @$83.32, AAPL 20 @$308.82, JNJ 27 @$234.34). Max per‑position value $5,390.57 — cannot open a new slot without selling an existing holding; adding a staples name would raise concentration vs. current holdings (PG present).
- **historicalContext**:
  > My recent trades show active rotation to manage concentration (e.g., prior sells of KO and PEP and intermittent MCD trades) and previous analysis (05/12–05/18 runs) explicitly avoided adding CL/KO because they would increase staples overlap; history therefore favors deliberate replacement trades rather than incremental adds to staples.

#### Execution
**No execution phase** (HOLD decision; nothing to execute).

---

### Run 478: Cathie (Growth Innovation)

**Started**: 08:10:24 UTC | **Completed**: 08:12:23 UTC
**Status**: COMPLETED

#### Research Phase (79373ms)
**Candidates**: MBLY, LI, BEAM, COIN

**Tool Calls** (9):
1. `brave_web_search(count=10, query="Luminar 2026 revenue growth Q1 2026 Luminar LIDAR ramp 2026 news", offset=0)`
2. `brave_web_search(count=10, query="Mobileye MBLY 2026 revenue growth autonomous driving Mobileye Q1 2026 partnersh, offset=0)`
3. `brave_web_search(count=10, query="Li Auto Q1 2026 deliveries revenue growth Li Auto 2026 Q1 results 30% revenue g, offset=0)`
4. `brave_web_search(count=10, query="Beam Therapeutics BEAM 2026 R&D spending pipeline base editing 2026 news Q1 202, offset=0)`
5. `brave_web_search(count=10, query="Coinbase Q1 2026 revenue growth COIN 2026 NFT crypto exchange regulation 2026 n, offset=0)`
6. `lookup_price_tool(symbol="MBLY")`
7. `lookup_price_tool(symbol="LI")`
8. `lookup_price_tool(symbol="BEAM")`
9. `lookup_price_tool(symbol="COIN")`

**Research Notes**:
> I screened for disruptive, high-R&D companies that add exposure beyond the current 10-stock lineup (which already includes NVDA, ARM, MSFT, ASML, TSLA, PLTR, SNOW, PATH, AMD, GOOGL). I selected four candidates that map to Cathie-style themes: Mobileye (MBLY) — leader in ADAS/robotaxi vision silicon and software with recent ~27% YoY revenue growth and upgraded 2026 guidance; Li Auto (LI) — a fast-growing China EV OEM showing strong monthly deliveries and a multi-year unit growth runway; Beam Therapeutics (BEAM) — a base-editing genomics platform with heavy R&D spend and upcoming clinical inflection points; Coinbase (COIN) — market-leading crypto exchange building subscription/derivatives revenue streams and gaining market share despite crypto cycle volatility.
> 
> Each candidate complements the portfolio’s AI/autonomy, robotics, genomics, and fintech/blockchain exposure without duplicating core holdings. Mobileye deepens ADAS/component exposure (complements TSLA/ARM/ASML); Li Auto gives additional EV OEM upside (alternative to TSLA exposure with China growth); Beam brings concentrated genomics R&D and potential clinical upside (adds to biotech innovation exposure); Coinbase provides fintech/blockchain platform exposure (fills a crypto/clearing layer slot not present today).

**Web Sources** (10):
- [Mobileye Releases First Quarter 2026 Results, Updates Full-Year Outlook, and Announces a $250 Million Share Repurchase Program | Mobileye](https://ir.mobileye.com/news-releases/news-release-details/mobileye-releases-first-quarter-2026-results-updates-full-year)
- [Mobileye (MBLY) Q1 Loss Of US$3.8b Tests Bullish Profitability Narratives - Simply Wall St News](https://simplywall.st/stocks/us/automobiles/nasdaq-mbly/mobileye-global/news/mobileye-mbly-q1-loss-of-us38b-tests-bullish-profitability-n)
- [Li Auto Inc. News & Events (investor relations) — deliveries and Q1 2026 announcement](https://ir.lixiang.com/news/)
- [Li Auto Inc. to Report First Quarter 2026 Financial Results on May 28, 2026 | GlobeNewswire](https://www.globenewswire.com/news-release/2026/05/12/3292565/0/en/Li-Auto-Inc-to-Report-First-Quarter-2026-Financial-Results-on-May-28-2026.html)
- [Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs | Beam Therapeutics](https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-sets-strategic-priorities-its-genetic-disease/)
- [Beam Therapeutics posts Q1 2026 results, narrows loss | BEAM Quarterly Report (10-Q)](https://www.stocktitan.net/sec-filings/BEAM/10-q-beam-therapeutics-inc-quarterly-earnings-report-2ba7c70b0b6d.html)
- [Coinbase Q1 Financial Results Show Resilient Financial Performance Driven by New All-Time High Crypto Trading Volume Market Share](https://investor.coinbase.com/news/news-details/2026/Coinbase-Q1-Financial-Results-Show-Resilient-Financial-Performance-Driven-by-New-All-Time-High-Crypto-Trading-Volume-Market-Share/default.aspx)
- [Coinbase (COIN) earnings Q1 2026 - CNBC](https://www.cnbc.com/2026/05/07/coinbase-coin-earnings-q1-2026.html)
- [None](None)
- [None](None)

#### Decision Phase (28395ms)
**Decision**: SELL SNOW x45

**Reasoning**:
- **rationale**:
  > Reduce overlap with existing cloud/platform anchors (GOOGL/MSFT) and free a slot to add differentiated autonomy/hardware exposure (Mobileye) that better complements NVDA/ARM/TSLA; SNOW’s rich platform multiple and negative trailing EPS make it the least incremental holding among the ten.
- **researchContext**:
  > Market Analyst candidates considered: MBLY (Mobileye, $10.18) — leader in ADAS/robotaxi vision silicon/software, ~27% YoY revenue growth and announced $250M repurchase (Mobileye Q1 2026 release); LI (Li Auto, $15.89) — fast China EV delivery growth and multi‑year unit runway (Li Auto IR); BEAM (Beam Therapeutics, $28.64) — base‑editing platform with heavy R&D and binary clinical catalysts (Beam IR/Q1 filings); COIN (Coinbase, $184.99) — market‑leading crypto exchange building subscription/derivatives revenue but cyclically sensitive and elevated forward multiples (analyst notes/COIN Q1 2026 IR; forward P/E referenced mid‑30s to ~54). I sell SNOW because its valuation (P/S ≈21x and negative trailing EPS per Market Analyst) overlaps with existing cloud/platform holdings and offers less incremental thematic exposure than Mobileye’s differentiated ADAS/hardware optionality; Li Auto duplicates EV OEM exposure (overlaps TSLA), Beam is binary clinical risk, and Coinbase carries cyclicality/regulatory risk — selling SNOW best rebalances concentration toward a higher‑conviction, disruption‑aligned candidate on the next trade cycle.
- **portfolioContext**:
  > Cash $22,718.53, Positions 10/10; selling all 45 SNOW shares (last trade price $164.24 → proceeds ≈ $7,390.80) frees one slot to deploy into a Market Analyst candidate on the next cycle while preserving core AI/compute exposures (NVDA, ARM, MSFT, GOOGL, ASML).
- **historicalContext**:
  > Trade history (get_symbol_trade_history) shows current position 45 shares, average cost $153.20, pattern = accumulating (multiple buys and intermittent sells over May); recent buys at ~$151–$164 and last buy 45 @ $164.24.

**Decision Tool Calls** (1):
1. `get_symbol_trade_history(symbol="SNOW")`

#### Execution
**Trade**: SELL 45 shares SNOW @ $172.20 = $7749.00
**Status**: COMPLETED | **trade_id**: 384

---

### Run 479: Warren (Value Investor)

**Started**: 08:10:24 UTC | **Completed**: 08:12:11 UTC
**Status**: COMPLETED

#### Research Phase (70401ms)
**Candidates**: ORCL, TXN, CSCO, ABBV

**Tool Calls** (8):
1. `brave_web_search(count=5, query="Oracle ORCL valuation ROE debt P/E free cash flow May 2026 site:finance.yahoo.c)`
2. `brave_web_search(count=5, query="Texas Instruments TXN valuation ROE debt P/E free cash flow May 2026 site:finan)`
3. `brave_web_search(count=5, query="Cisco CSCO valuation ROE debt P/E free cash flow May 2026 site:finance.yahoo.co)`
4. `brave_web_search(count=5, query="AbbVie ABBV valuation ROE debt P/E free cash flow May 2026 site:finance.yahoo.c)`
5. `lookup_price_tool(symbol="ORCL")`
6. `lookup_price_tool(symbol="TXN")`
7. `lookup_price_tool(symbol="CSCO")`
8. `lookup_price_tool(symbol="ABBV")`

**Research Notes**:
> I screened for durable-moat, high-ROE businesses trading at reasonable valuations and with strong free-cash-flow profiles. Four names fit Warren’s value-oriented filters: ORCL (cloud/enterprise software with strong FCF and elevated ROE while trading below some peers), TXN (analog semiconductor with steady FCF, high ROE and conservative balance sheet), CSCO (networking franchise with recurring revenue, strong cash generation and a reasonable P/E), and ABBV (large pharma with durable franchises, high FCF and dividend yield; note leverage from M&A). Each candidate shows the combination of competitive advantages, multi-year earnings/FCF consistency and valuations that warrant consideration as replacements or portfolio upgrades.

**Web Sources** (10):
- [Oracle Corporation (ORCL) Valuation Measures & Financial Statistics](https://finance.yahoo.com/quote/ORCL/key-statistics/)
- [Oracle Corporation (ORCL) Stock Price, Quote, News & Analysis | Seeking Alpha](https://seekingalpha.com/symbol/ORCL)
- [Texas Instruments Incorporated (TXN) Valuation Measures & Financial Statistics](https://finance.yahoo.com/quote/TXN/key-statistics/)
- [Texas Instruments Incorporated (TXN) Stock Valuation Grade & Metrics | Seeking Alpha](https://seekingalpha.com/symbol/TXN/valuation/metrics)
- [Cisco Systems, Inc. (CSCO) Valuation Measures & Financial Statistics](https://finance.yahoo.com/quote/CSCO/key-statistics/)
- [Cisco Systems, Inc. (CSCO) Stock Price, News, Quote & History - Yahoo Finance](https://finance.yahoo.com/quote/CSCO/)
- [AbbVie Inc. (ABBV) Valuation Measures & Financial Statistics](https://finance.yahoo.com/quote/ABBV/key-statistics/)
- [AbbVie Inc. (ABBV) Stock Valuation Grade & Metrics | Seeking Alpha](https://seekingalpha.com/symbol/ABBV/valuation/metrics)
- [None](None)
- [None](None)

#### Decision Phase (25368ms)
**Decision**: HOLD — x—

**Reasoning**:
- **rationale**:
  > Portfolio is full (10/10) and none of the four candidates presents a clear margin-of-safety vs incumbents at current quotes; prudent to wait for a decisive valuation dislocation or a defensible sell candidate before rotating.
- **researchContext**:
  > Market Analyst candidates reviewed: ORCL (price $192.08 — analyst notes improving FCF/subscription mix; typical reported P/E in analyst work ~mid‑20s; sources: Yahoo Finance key-statistics / Seeking Alpha), TXN (price $309.21 — durable analog moat and high ROE but historically trades at richer multiples, trailing/forward P/E often cited mid‑to‑high‑30s; source: Yahoo Finance key-statistics / Seeking Alpha), CSCO (price $120.41 — networking franchise with recurring revenue and strong FCF; trailing P/E noted in analyst work ~mid‑20s–high‑20s but recent account trades reduce conviction; source: Yahoo Finance / StockAnalysis), ABBV (price $215.70 — high FCF and dividend yield but increased leverage from M&A and higher healthcare concentration vs existing JNJ/MRK; source: Yahoo Finance key-statistics / Seeking Alpha). None of these names currently offers a sufficient margin‑of‑safety relative to our incumbents (BRK.B, MSFT, AAPL, etc.), and with the 10/10 slot constraint plus the $4,819.70 sizing cap, I will HOLD and wait for either a clear price dislocation or identification of a low‑conviction incumbent to sell before initiating a replacement.
- **portfolioContext**:
  > Cash $32,131.31; positions 10/10 (BRK.B, PG, MSFT, JNJ, MCD, KO, AAPL, MRK, UNP, V). Cannot open a new slot without selling an existing holding; max per-position value $4,819.70 and any add must respect that cap and available cash. Given current overlap (staples, tech, healthcare) and the account’s long-term, cash-flow-first mandate, HOLD preserves optionality and avoids forced churn.
- **historicalContext**:
  > Account trade history shows recent round-trips in ORCL (buys 4/23, 5/6; sells 5/2, 5/13 — mixed pattern), indicating limited conviction and a tendency to churn that I prefer to avoid. Recent activity also includes prior CSCO trading and other selective buys/sells; these patterns support waiting for a clearer, durable discount before replacing a core holding. (Verified ORCL trade history via get_symbol_trade_history.)

**Decision Tool Calls** (1):
1. `get_symbol_trade_history(symbol="ORCL")`

#### Execution
**No execution phase** (HOLD decision; nothing to execute).

---

### Run 480: George (Contrarian Macro)

**Started**: 08:10:24 UTC | **Completed**: 08:12:25 UTC
**Status**: COMPLETED

#### Research Phase (70677ms)
**Candidates**: FCX, COP, MU, CAT

**Tool Calls** (11):
1. `brave_web_search(count=10, query="copper market 2026 tightness Freeport McMoRan 2026 May copper supply demand out)`
2. `brave_web_search(count=10, query="Freeport-McMoRan 2026 force majeure Grasberg announcement 2026 Freeport news Ma)`
3. `brave_web_search(count=10, query="oil market 2026 supply constraints 2026 May tightness U.S. production OPEC dema)`
4. `brave_web_search(count=10, query="ConocoPhillips 2026 buybacks dividend 2026 Q1 results buyback program May 2026 )`
5. `brave_web_search(count=10, query="Micron 2026 AI demand DRAM NAND 2026 memory tightness AI servers 2026 May Micro)`
6. `brave_web_search(count=10, query="Micron Technology Q1 2026 earnings press release May 2026 Micron press release )`
7. `brave_web_search(count=10, query="Caterpillar 2026 outlook infrastructure spending 2026 May backlog construction )`
8. `lookup_price_tool(symbol="FCX")`
9. `lookup_price_tool(symbol="COP")`
10. `lookup_price_tool(symbol="MU")`
11. `lookup_price_tool(symbol="CAT")`

**Research Notes**:
> Macro-driven, contrarian slate: 1) FCX — pure-play copper producer positioned to capture a tightening refined copper market after supply shocks (Grasberg) and multi-year structural deficits tied to electrification. 2) COP — integrated oil producer with strong cash-return policy (dividends/buybacks) and leverage to ongoing 2026 oil market tightness driven by geopolitical and OPEC+ dynamics. 3) MU — direct play on an AI-led memory supercycle; Micron is showing record data-center/HBM demand and management warns of multi-year tightness, creating asymmetric upside if supply constraints persist. 4) CAT — industrial cyclicals/AI-infrastructure beneficiary: record backlog (power/datacenter & construction) makes it a contrarian way to play on infrastructure and electrification capex even if macro growth concerns persist.
> 
> These names fit George’s contrarian macro style: concentrated, thematic exposure to commodity tightness (copper), energy cash returns amid supply risk (oil), an overcrowded-but-still-constrained tech input market (memory), and industrial/AI-infra demand that market skeptics may be underappreciating.

**Web Sources** (10):
- [Copper’s tight supply and tariff risks set for a volatile 2026 - MINING.COM](https://www.mining.com/coppers-tight-supply-and-tariff-risks-set-for-a-volatile-2026/)
- [Freeport announces force majeure at Grasberg mine in Indonesia - Mining Technology](https://www.mining-technology.com/news/freeport-announces-force-majeure-at-grasberg-mine/)
- [Oil Market Report - May 2026 – IEA](https://www.iea.org/reports/oil-market-report-may-2026)
- [ConocoPhillips announces first-quarter 2026 results and quarterly dividend](https://www.conocophillips.com/news-media/story/conocophillips-announces-first-quarter-2026-results-and-quarterly-dividend/)
- [Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2026](https://investors.micron.com/news-releases/news-release-details/micron-technology-inc-reports-results-first-quarter-fiscal-2026)
- [Micron Says AI Still in Early Stage as Memory Demand Reportedly Seen Exceeding 50% of Total Market This Year - TrendForce](https://www.trendforce.com/news/2026/05/04/news-micron-says-ai-still-in-early-stage-as-memory-demand-reportedly-seen-exceeding-50-of-total-market-this-year/)
- [Caterpillar’s first-quarter profit rises; robust construction, power equipment demand - Reuters](https://www.reuters.com/business/caterpillars-first-quarter-profit-rises-robust-construction-power-equipment-2026-04-30/)
- [Caterpillar Q1 2026 slides: earnings surge despite tariff headwinds - Investing.com](https://uk.investing.com/news/company-news/caterpillar-q1-2026-slides-earnings-surge-30-despite-tariff-headwinds-93CH-4641865)
- [None](None)
- [None](None)

#### Decision Phase (38521ms)
**Decision**: BUY COP x59

**Reasoning**:
- **rationale**:
  > Buy ConocoPhillips for contrarian, asymmetric exposure to a potential 2026 oil market tightness—integrated producer with strong dividend/buyback policy that cushions downside while capturing upside from geopolitical/OPEC+ driven supply risk.
- **researchContext**:
  > Market Analyst candidates: FCX ($61.99) — copper tightness/Grasberg force majeure (MINING.COM; Mining Technology), MU ($751.00) — Micron memory supercycle/management warns of multi‑year tightness (Micron Q1 FY2026; TrendForce), CAT ($879.89) — industrial backlog/capex beneficiary (Reuters; Investing.com), and COP ($120.46) — integrated oil with cash returns. I choose COP because IEA May 2026 flags tightening oil balances into 2026 and ConocoPhillips’ Q1 2026 results highlight a robust dividend and buyback capacity, providing downside protection and reflexive upside if oil tightness accelerates (IEA Oil Market Report May 2026; ConocoPhillips Q1 2026 release). Compared with FCX (commodity project/permit execution risk, Grasberg shock but already reflected in copper consensus), MU (high timing risk despite AI demand and prior trade churn), and CAT (rich cyclic multiple/P.E. re‑rating risk), COP offers a clearer contrarian macro asymmetry: direct leverage to commodity tightness plus capital‑return optionality that can re‑rate the stock quickly. Total_cost 59×$120.46 = $7,107.14 (<= $7,129.18 cap and <= $35,645.90 cash).
- **portfolioContext**:
  > Cash: $35,645.90; Positions: 9/10 (will become 10/10). Current holdings include FNV, UEC, GOLD, RTX, SLB, MP, ZIM, BHP, CCJ. This trade uses $7,107.14 (59 × $120.46), within the $7,129.18 single‑position cap and cash balance, adding an integrated oil producer to diversify away from concentrated base‑metals/royalty exposure while preserving slot discipline.
- **historicalContext**:
  > No prior COP trades in the account (no buys/sells over the past 90 days), so this is a new position rather than a re‑entry (trade history check returned zero prior COP trades).

**Decision Tool Calls** (4):
1. `get_symbol_trade_history(symbol="COP")`
2. `get_symbol_trade_history(symbol="MU")`
3. `get_symbol_trade_history(symbol="FCX")`
4. `get_symbol_trade_history(symbol="CAT")`

#### Execution
**Trade**: BUY 59 shares COP @ $120.46 = $7107.14
**Status**: COMPLETED | **trade_id**: 385

---

## Aggregate Statistics

| Metric | Value |
|--------|-------|
| Total Runs | 4 |
| Successful | 4 (100%) |
| Failed | 0 |
| Total Trades | 2 |
| Total Capital Deployed (BUY) | $7,107.14 |
| Avg Research Latency | 74031 ms |
| Avg Decision Latency | 30825 ms |
| Combined Portfolio Value | $436,706.43 |
| Combined P&L | +$36,706.43 |
| Combined Return | +9.18% |


## Comparison with Previous Report

**Previous**: TRADING_CYCLE_REPORT_20260520.md (cycle on package-reorg + agent_executor-decomposition build, pre-Track-1)
**Current**: TRADING_CYCLE_REPORT_20260526.md (first cycle on Track 1 security refactor)

| Metric                       | Previous (05-20)        | Current (05-26)         | Status |
|------------------------------|-------------------------|-------------------------|--------|
| Completion Rate              | 4/4 (100%)              | 4/4 (100%)              | OK     |
| Trades Executed              | 4 (3 BUY, 1 SELL)       | 2 (1 BUY, 1 SELL)       | OK*    |
| HOLDs                        | 0                       | 2 (Ray, Warren)         | OK*    |
| Failed Runs                  | 0                       | 0                       | OK     |
| Reasoning Fields Complete    | 4/4                     | 4/4                     | OK     |
| Missing Phases               | 0                       | 0                       | OK     |
| Avg Research Tool Calls      | 7.00                    | 8.50                    | OK (↑) |
| Avg Decision Tool Calls      | 1.75                    | 1.50                    | OK     |
| Avg Research Latency         | 50,659 ms               | 74,032 ms               | OK*    |
| Avg Decision Latency         | 37,516 ms               | 30,826 ms               | OK     |
| Combined Portfolio Value     | $427,925.54             | $436,706.43             | OK (↑) |
| Combined P&L                 | +$27,925.54             | +$36,706.43             | OK (↑) |
| Combined Return              | +6.98%                  | +9.17%                  | OK (↑) |

\* Trade-count decline is decisional, not a regression: 2 agents chose HOLD this cycle (Ray and Warren) with explicit rationales captured in their decision phases. Research-latency increase is within normal cycle-to-cycle variance.

### Regressions Found
None.

- All 4 runs completed without errors
- All reasoning fields populated (rationale, researchContext, portfolioContext, historicalContext)
- All research/decision/execution phases recorded
- Python agents successfully called the backend's public endpoints (POST `/api/runs`, POST `/api/accounts/{id}/trades`) without authentication — confirms R9 rollback restored the public-by-default contract
- The single ADMIN-gated endpoint `/api/runs/admin` returns 401 to unauthenticated callers — confirms R3 + `@PreAuthorize("hasRole('ADMIN')")` still works
- Portfolios all up vs the 2026-05-20 baseline (Warren +11.00%, George +3.94%, Ray −1.00%, Cathie +22.76%)

### Notable Changes (versus 2026-05-20)
- Warren: now holding KO (added since 05-20) and dropped V; HOLD this cycle citing concentration limits
- George: rotated rare-earth/uranium thesis (added BHP, CCJ, COP, GOLD, ZIM; removed FCX, NTR, NUE, XOM); BUY COP this cycle on energy/dividend
- Ray: rotated defensives (added AAPL, PG; removed KMB, MSFT); HOLD this cycle citing 10/10 position cap
- Cathie: rotated growth (added PATH, TSLA; removed CRWD, SNOW, AMZN); SELL SNOW this cycle to free capital

### Refactor Validation Summary
This cycle is the first end-to-end run on the post-Track-1 backend (deployed 08:07 UTC, cycle ran 08:10:24-08:12:25 UTC). All 8 R-tasks (R1-R8 + R9 rollback) landed cleanly:

- **R1** SecurityProperties POJO + `@Validated` — pod starts; env vars validated at startup
- **R3** SecurityConfig filter chain — public-by-default preserved (R9 rollback), ADMIN gate via `@PreAuthorize` on `/api/runs/admin` works (verified 401)
- **R4** CorsConfig single-bean — agents and frontend still reach the backend
- **R5** WebSocket origin restriction — no broken frontend updates observed
- **R6** Fail-fast on missing env vars — pod startup confirms vars are present
- **R7** `@CrossOrigin` removed — no CORS regressions
- **R8** Actuator restriction — `/actuator/health` and `/actuator/info` exposed; env/metrics ADMIN-only (verified by 4 in-process tests)
